Research Article

ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma

Figure 4

Survival analysis curve of the ESM1 high-expression and low-expression groups. Red and blue represent the ESM1 high- and low-expression groups, respectively. (a) The higher expression of ESM1, the worse prognosis of OS (, 95% CI 1.01-1.42, and ), (b) PFI (, 95% CI 0.96-1.33, and ), and (c) DSS (, 95% CI 1.11-1.62, and ). (d) DFI was longer in the ESM1 high-expression group.
(a)
(b)
(c)
(d)